Horizon Therapeutics PLC - ESG Rating & Company Profile powered by AI
If you are employed by Horizon Therapeutics PLC and you wish to use your Sustainability aseessment, please get in touch. The ESG score includes seventeen United Nations SDGs including: 'Clean Water & Sanitation', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. The ESG assessment for Horizon Therapeutics PLC represents the company's reporting of the United Nations SDGs.
Horizon Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.7; made up of an environmental score of 4.0, social score of 6.0 and governance score of 1.1.
3.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1112 | XSpray Pharma AB (publ) | 3.8 | Medium |
| 1112 | Zhongzhi Pharmaceutical Holdings Ltd | 3.8 | Medium |
| 1132 | Horizon Therapeutics PLC | 3.7 | Medium |
| 1132 | Chemometec A/S | 3.7 | Medium |
| 1132 | BEACON Pharmaceutical Ltd | 3.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Horizon Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Horizon Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Horizon Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Horizon Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Horizon Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Horizon Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Horizon Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Horizon Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Horizon Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Horizon Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Horizon Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Horizon Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Horizon Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Horizon Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Horizon Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Horizon Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Horizon Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Horizon Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. Its orphan and rheumatology marketed medicines include KRYSTEXXA, a medicine for the treatment of uncontrolled gout; RAVICTI for use as a nitrogen-binding agent for chronic management of adult and pediatric patients; PROCYSBI for nephropathic cystinosis, a rare and life-threatening metabolic disorder; ACTIMMUNE for chronic granulomatous disease; RAYOS for the treatment of multiple conditions, rheumatoid arthritis; BUPHENYL tablets for oral administration and BUPHENYL powder for oral, nasogastric, or gastrostomy tube administration; and QUINSAIR, a formulation of the antibiotic drug levofloxacin for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis. The company's primary care marketed medicines comprise PENNSAID 2% that is indicated for the treatment of pain of osteoarthritis of the knees; DUEXIS for the relief of signs and symptoms of RA and OA, and to decrease the risk of developing upper-GI ulcers; VIMOVO for the relief of signs and symptoms of OA, RA, and AS and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers; and MIGERGOT, a therapy to abort or prevent vascular headaches, such as migraines and migraine variants. It has collaboration agreements with Alliance for Lupus Research, Syneos Health, Inc., and HemoShear Therapeutics, LLC. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.